KIT and acute myeloid leukemia: Upregulation of the immune checkpoints CD155 and CD47 was observed on cKit+ malignant cells from Vav-cre Tet2fl/flTp53fl/fl mice and in myeloid malignant cells from patients with TP53/TET2 double-mutant AML.